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Transcription factor 4 (TCF4) is a class I basic helix-loop-helix (bHLH) transcription factor which 
regulates the neurogenesis and specialization of cells. TCF4 also plays an important role in the 
development and functioning of the immune system. Additionally, TCF4 regulates the development 
of Sertoli cells and pontine nucleus neurons, myogenesis, melanogenesis and epithelial-mesenchymal 
transition. The ability of transcription factors to fulfil their function often depends on their intracellular 
trafficking between the nucleus and cytoplasm of the cell. The trafficking is regulated by specific 
sequences, i.e. the nuclear localization signal (NLS) and the nuclear export signal (NES). We performed 
research on the TCF4 trafficking regulating sequences by mapping and detailed characterization of 
motifs potentially acting as the NLS or NES. We demonstrate that the bHLH domain of TCF4 contains an 
nLS that overlaps two neSs. the results of in silico analyses show high conservation of the sequences, 
especially in the area of the nLS and neSs. this high conservation is not only between mouse and 
human TCF4, but also between TCF4 and other mammalian E proteins, indicating the importance of 
these sequences for the functioning of bHLH class i transcription factors.
Transcription factor 4 (TCF4), also known as immunoglobulin transcription factor 2 (ITF2) or SL3-3 enhancer 
factor 2 (SEF2), belongs to the family of ubiquitously expressed transcription factors that contain a basic 
helix-loop-helix (bHLH) domain. It plays an important role in a number of developmental processes1. There are 
four known mammalian representatives of class I bHLH (E proteins) transcription factors. In addition to TCF4, 
to this class also belong: E12 and E47 (E2a/TCF3 isoforms), and HEB (human E-box binding factor)/TCF12. The 
bHLH domain is responsible for homo- and heterodimer formation with other bHLH transcription factors (TFs). 
The region of basic amino acid residues of the bHLH domain facilitate DNA binding, indispensable for the role 
of transcription factors, while their function and activity is regulated by activation and repressor domains2. TCF4 
binds the canonical enhancer-box (E-box) sequence 5′-CANNTG-3′3 and influences chromatin remodelling and 
transcription through the recruitment of p300 with histone acetyltransferases (HATs) activity4. TCF4 is known 
to exist in many isoforms, which are generated by the usage and splicing of alternative 5′ exons5. These isoforms 
differ in terms of the presence of activation and repressor domains6.
TCF4 expression was reported in different organs: brain, heart, kidney, lungs, muscle, spleen and testis, and in 
lesser amounts in the liver, prostate and ovaries7. It was shown that TCF4 is involved in the differentiation of plas-
macytoid dendritic cells that form part of the adaptive immune system. TCF4 is also crucial for the development 
of lymphoid progenitor cells, giving rise to T- and B-lineage cells8. Additionally, TCF4 regulates the development 
of Sertoli cells, myogenesis, melanogenesis and epithelial-mesenchymal transition5.
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A particularly high-level expression of TCF4 is observed in the embryonic central nervous system, meso-
derm and adult brain9. TCF4 regulates the neurogenesis and differentiation of cells by forming heterodimers 
with proneuronal activators belonging to the bHLH family, like achaete-scute homolog 1 (ASCL1), protein atonal 
homolog 1 (ATOH1) and neurogenic differentiation factor 1 (NEUROD1). Conversely, the interaction of TCF4 
with the DNA-binding protein inhibitor ID-2 (ID2) results in the formation of an inactive heterodimer, thus 
blocking TCF4 binding with activators10. To date, not much is known about the role of TCF4 in the central 
nervous system. However, in situ tests have shown that TCF4 is an important factor in the regulation of glial cell 
differentiation, especially the maturation of oligodendrocyte progenitors, and it also plays an important role in 
the regulation of the nuclei development of the pons involved in motor activity11–13.
Over the last several years, TCF4 has been linked to many diseases, mainly brain disorders. Genome analysis 
has revealed common variants in TCF4 as susceptibility loci for schizophrenia. This disease was first linked to 
the TCF4 gene by Stefansson14, who reported a single-nucleotide polymorphisms associated with this gene. Later, 
studies of Chinese patients15 confirmed this relationship by finding additional polymorphisms. Another disease 
with characteristics similar to schizophrenia is bipolar disorder, which is characterized by alternating episodes of 
depression and mania. Performed studies revealed a decreased expression level of TCF4 in the case of both these 
disorders8. In 2007, three independent research groups revealed that the TCF4 gene was linked to the presence of 
the mental disorder Pitt-Hopkins Syndrome (PHS). Most mutations that cause PHS are located within the bHLH 
domain of the protein. For this reason, its interaction with DNA and other proteins is impaired16–18. Additionally, 
common TCF4 gene variants are risk factors for non-psychotic disorders like Fuchs’corneal endothelial dystrophy 
(FECD)19,20 and primary sclerosing cholangitis (PSC)21.
In eukaryotes, one of the most important organelles is the cell nucleus. The cytoplasmic and nuclear compart-
ments of the cell are separated by a double protein-lipid layer containing nuclear pore complexes that allow for 
passive and active transport of molecules in two directions. Precise regulation and proper localization is crucial 
for the ability of protein to act as an active transcription factor22. Molecules not exceeding 40 kDa can be trans-
ported in a passive way23. However, larger particles shuttle by the nuclear pore complex (NPC) in an active way 
due to their interaction with Karyopherins, which recognize specific motifs within the sequence of transported 
proteins24. Importins recognize the nuclear localization signal (NLS), typically rich in basic amino acid residues, 
and exportins recognize the nuclear export signal (NES), which is less conservative. One of the characteristics of 
a classical NES is the presence of multiple leucine or isoleucine residues25,26. Leptomycin B (LMB) as an inhibitor 
of exportin-1 dependent transport from the nucleus to the cytoplasm and is often used in experimental verifica-
tion of NES activity27–29. Detection of the NES and NLS is not simple and is unambiguous. These signal activities 
are not only dependant on the occurrence of specific amino acid residues, but also on the secondary structure of 
the protein, its flexibility and surface exposure26, post-translational modifications, and interactions with other 
proteins25.
The first report concerning subcellular localization of TCF4 showed this transcription factor to be only in the 
nucleus3, while related proteins from the class I bHLH family, like E2a and HEB, were detected both in nuclear 
and cytoplasmic fractions of human embryonic stem cells30. Detailed studies examining the expression of iso-
forms of TCF4 that differ in their N-terminal and internal sequences revealed that isoforms vary in terms of their 
subcellular localization. The longest isoform B presented a strictly nuclear localization, while others were present 
in both the nuclei and cytoplasm of HEK 293 cells and human brain tissue5. Later on, Brandl et al.31 investigated 
TCF4 distribution in human colorectal carcinomas cells. They showed that TCF4 localization in the cytoplasm 
was positive in 76% of cases, while localization in the nucleus was positive in 51% of cases. Importantly, the 
cytoplasmic localization of TCF4 was correlated with better survival. Cytoplasmic localization of TCF4 was also 
observed by d’Rosario et al.32. In their research, TCF4 was only detected in the nuclei of some neurons, while in 
the cytoplasm (soma and dendrites) it was seen in most post-mitotic neurons. Sepp et al.33 did not agree with 
these results. They presented results of the overexpression of different isoforms of TCF4 in the primary neurons of 
rats, which were fully consistent with previously published results5. The authors also declared that the regulation 
of TCF4 by neuronal activity cannot be attributed to its signal-dependent nuclear import. Finally, in 2018, Jung 
et al.34 showed that TCF4 expression in the lateral (LA) and basolateral (BLA) nuclei in the amygdala of young 
adult mice was nuclear, while in the central amygdala nucleus (CEA) the TCF4 was located in fibers and not in 
the nucleus. The authors suggested the possibility that TCF4 activity could be modulated by nuclear-cytoplasmic 
translocation.
Due to the discrepancies presented above, we decided to systematically analyse the presence of putative NLSs 
and/or NESs and their role in subcellular trafficking of TCF4-B isoforms. We demonstrate that TCF4 contains 
an NLS that is partially overlapping with two LMB-sensitive NESs in the bHLH domain. The location of the NLS 
and NESs in close proximity raises the possibility of alternating the activity of these signals and suggests that the 
interaction of the NLS with importin prevents the interaction of NESs with exportin and vice versa. This dynamic 
might be important in the regulation of TCF4 cellular shuttling. Interestingly, our experiments showed no NES 
activity for the previously suggested predicted motif in the N-terminal part of protein (aa 10–19)32. Additionally, 
we proposed that the previously documented NLS (156–178 aa)5 might function as a Nucleolar localization sig-
nal (NoLS). In silico analysis shows high conservation of NLSs and NESs between TCF4 and related mammalian 
proteins, indicating the importance of these sequences for the general regulation of class I bHLH transcription 
factors subcellular shuttling, and in consequence, also their function.
Results
Subcellular localization of TCF4 in COS-7 and N2a cells. Previously it was shown that green fluores-
cent protein (GFP) can be used for monitoring protein expression and localization in living organisms35, and 
yellow fluoresce protein (YFP) did not influence localization of the related TCF4 and E47 protein36. Twenty-
four hours after transient transfection of the COS-7 and N2a cells, we analyzed the subcellular localization of 
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N-terminally YFP-tagged full-length TCF4 using fluorescent microscopy. The expression of YFP-TCF4, and in 
further experiments YFP-tagged TCF4 mutants in the COS-7 cells, was confirmed by western blot analysis using 
an anti-GFP antibody (Fig. S1). As the expression of TCF4 was documented in various tissues7, we decided to 
use two different cell lines: COS-7 cells used previously for bHLH protein localization studies37,38 and Neuro2A 
mouse neuroblastoma (N2a) cells with a documented expression of TCF45. The distribution of TCF4 fused with 
YFP in more than 95% of COS-7 cells was strictly nuclear (Fig. 1a,a’), however there were some cells (less than 
5%) presenting fluorescence not only in the nucleus, but also in the cytoplasm in the puncta that were non-uni-
formly distributed in the cytoplasm of cells (Fig. S2). In the case of the N2a cells, the expression of YFP-TCF4 was 
exclusively nuclear (Fig. 1b,b’). As proof that YFP does not influence TCF4 localization, we expressed the YFP 
protein alone in the COS-7 (Fig. 1 c) and N2a cells (Fig. 1d), which, as expected, resulted in ubiquitous localiza-
tion. Differences in localization of TCF4, depending on the cell type and literature data presented here, led us to 
the hypothesis about the putative presence of the composite system of NLSs and NESs in TCF4. This hypothesis is 
substantiated by a previous report indicating that related proteins, E2a and HEB, can be observed in the nucleus 
and cytoplasm of human embryonic stem cells (hESCs)30.
The N-terminal fragment of the canonical TCF4-B isoform do not possess an active NES. It was 
previously suggested that the N-terminal region of TCF4 could contain an active NES, however experimental ver-
ification of prediction was not performed39. We repeated in silico analysis using currently available NES predictors 
and obtained the same positive results for 10–19 aa (Fig. 2Aa). To experimentally test the activity of putative NES, we 
prepared deletion fragments comprising amino acid residues 1–30, 31–146, and 1–146 fused C-terminally to YFP 
(Fig. 2B). The expression of YFP-TCF4/1–30 (Fig. 2Ca,a’), YFP-TCF4/31–146 (Fig. 2Cb,b’) and YFP-TCF4/1–146 
(Fig. 2Cc,c’) in the COS-7 and N2a cells resulted in the ubiquitous distribution of fluorescence throughout the whole 
cell. These results show that the sequence predicted by the NetNES server (Fig. 2Aa) is not an active NES in this 
region. The lack of activity can be explained by results of in silico analysis by NetSurfP, showing that leucine residues 
important for classical NES are predicted to be not exposed to the surface of the protein (Fig. 2Ab).
previously determined nLS can act as noLS. When testing the localization of different isoforms of 
TCF4, Sepp with co-workers5 identified bipartite NLS in the region of 8–9 exons of TCF4 comprising amino 
acid residues 156–178 in the TCF4-B isoform. This NLS was shown to be conserved among E-proteins5,40. 
We prepared YFP-tagged truncation mutants of TCF4 containing this area (Fig. 3A). The expression of 
YFP-TCF4/147–187 resulted in a strictly nuclear fluorescence in the COS-7 cells (Fig. 3Ba). Importantly, nucle-
olar localization was observed, which was proven by the staining with Draq5 dye that was used for visualiza-
tion of chromatin and nucleoli positions (Fig. 3Ba’). Moreover, in the case of YFP-TCF4/147–187 expression in 
the N2a cells, we observed fluorescence in both the nuclei and nucleoli (Fig. 3Bb). Interestingly, the expression 
Figure 1. Subcellular distribution of full-length TCF4. Subcellular localization of YFP-tagged TCF4 was 
analysed by confocal microscopy 20-24 h after transfecting COS-7 and N2a cells. Draq5 was added to the cells 
for DNA visualization. Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar 
compartments are presented as an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a) 
Representative images (single confocal plane) of the subcellular distribution of YFP-TCF4 (a-b’) and YFP (c-d) 
in COS-7 and N2a cells. Bar, 10 µm. no- nucleolus; nu- nucleus, cyt- cytoplasm.
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of YFP-TCF4/31–187 resulted in the same results for both the COS-7 (Fig. 3Bc,c’) and N2a (Fig. 3Bd) cells, 
while YFP-TCF4/147–300 presented only nuclear, and not nucleolar localization. Instead, some punctate pattern 
appeared in the nuclei of the COS-7 cells (Fig. 3Be,e’), and to a lesser extent in the N2a cells (Fig. 3Bf).
Figure 2. Subcellular distribution of deletion mutants (1-146aa) of TCF4 (A) Results of NetNES1.1(a) and 
NetSurfP (b) Predictors (B) Schematic representation of TCF4 protein. Regions of the TCF4 (NLS and SMART 
predicted bHLH) are depicted using different patterns and upper numbering of aa residues. The length of each 
domain in the diagram is arbitrary. Bottom aa residues refer to first aa residues of all TCF4 fragments used in this 
study. Region of actual studied area of TCF4 is shown by the red rectangle. Expressed deletion mutants of TCF4 are 
depicted as arrows and particular deletion mutants are depicted as arrows. The same fashion is used for Figs 2–4 and 
6–10 (C) Subcellular distribution of deletion mutants of TCF4. Subcellular localizations of the expressed proteins 
were analysed by confocal microscopy 20-24 h after transfecting COS-7 and N2a cells. Representative images (single 
confocal plane for confocal microscopy) of subcellular distribution of the derivatives of the TCF4/1-146 area. 
Bar, 10 µm. Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar compartments are 
presented as an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a,a’) YFP-TCF4/1-30, (b,b’) 
YFP-TCF4/31-146, (c,c’) YFP-TCF4/1-146, (C) Results of NetNES1.1(a) and NetSurfP (b) Predictors.
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Previous research by Słomnicki et al.41 detected the nucleolar presence of TCF4 in primary cultures of fore-
brain neurons and astrocytes. We performed in silico prediction of the nucleolar localization signal (NoLS) in 
TCF4 with a Nucleolar localization sequence Detector (NoD) and got negative results. However, prediction of the 
NoLS is characterized by low accuracy and needs experimental verification42. A typical characteristic of the NoLS 
is the high presence of basic amino acid residues that are located in the alpha-helical and easily accessible region 
on the surface of the protein. There are three known classes of NoLSs and NLSs: NoLS-only signals, NLS-only sig-
nals and the joint NoLS-NLS region containing an overlapping NLS and NoLS42. As all characteristics necessary 
for acting as a NoLS possess a NLS (156–178aa) in the TCF4, we propose that this NLS may present additional 
Figure 3. Subcellular distribution of deletion mutants (147-300aa) of TCF4 (A) Schematic representation of 
TCF4 protein. Region of the studied area of TCF4 is shown by the red rectangle. Expressed deletion mutants of 
TCF4 are depicted as arrows. The length of each domain in the diagram is arbitrary. (B) Subcellular distribution 
of deletion mutants of TCF4. Subcellular localizations of the expressed proteins were analysed by confocal 
microscopy 20-24 h after transfecting COS-7 and N2a cells. Representative images (single confocal plane) of 
subcellular distribution of the derivatives of the TCF4/31-300 area. Bar, 10 µm. Draq5 was added to the cells 
for DNA visualization. Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar 
compartments are presented as an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a,a’,b) 
YFP-TCF4/147-187, (c,c’,d) YFP-TCF4/31-187, (e-f) YFP-TCF4/147-300.
6Scientific RepoRtS |         (2019) 9:15629  | https://doi.org/10.1038/s41598-019-52239-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
NoLS activity that is regulated by an unknown mechanism (potentially posttranslational modification or inter-
action with a masking NoLS activity partner) that maybe uses some of the amino acid residues present in the 
188–300 area of the TCF4.
No active localization signal exists in the central part of TCF4. NLS predictors recognize 
classical signals rich in basic amino acid residues, while the last few years has also seen the discovery of 
proline-tyrosine-NLSs43. Moreover, NES appears to be a complex and diverse signal, not always being a classical 
leucine-rich motif44. To systematically test the presence of potential sequences that influence subcellular local-
ization in the central region of TCF4, we analysed fragments of this region fused C-terminally to YFP. These 
TCF4 fragments were defined according to the secondary structure prediction, which was performed using 
PSIPRED (data not shown). Eventually, four fragments, encompassing residues: 188–300, 301–367, 368–410 and 
411–549 were selected (Fig. 4A). The expressed proteins: YFP-TCF4/188–300 (Fig. 4Ba,a’), YFP-TCF4/301–367 
(Fig. 4Bb,b’), YFP-TCF4/368-410 (Fig. 4Bc,c’) and YFP-TCF4/411-549 (Fig. 4Bd,d’) presented uniform dis-
tribution between the nucleus and cytoplasm in the COS-7 and N2a cells. To guarantee that we did not dis-
rupt any structural motif in the constructs presented above, we also prepared fused versions of the previously 
selected fragments (Fig. 4A). Similarly to the results described above, YFP-tagged TCF4/188-367 (Fig. 4Be,e’), 
YFP-TCF4/301-410 (Fig. 4Bf,f ’) and YFP-TCF4/368-549 (Fig. 4Bg,g’) were ubiquitously distributed in the COS-7 
and N2a cells. As no NLS or NES motif was predicted in this area, this result proved the lack of active subcellular 
localization signals in this region under the used conditions.
The bHLH domain of TCF4 possesses an overlapping NLS and two NES motifs. It was previously 
shown that the full length GFP tagged bHLH domain of TCF4 was present in the nucleus and cytoplasm of the 
HEK293 cells, while the expression of the separated N- and C-terminal parts of this domain resulted in cytoplas-
mic localization of both truncations5. As previously published data did not unambiguously define the molecular 
features that affect subcellular distribution of the bHLH domain, we decided to perform a detailed study of this 
area. We asked the question about the presence of putative NESs and NLSs in fragments containing bHLH using 
different predictors. According to CDD (conserved domain database), a resource for the annotation of functional 
units in proteins, homology area of bHLH of TCF4 was shown for aa residues 553-634 in contrast to predicted 
by Smart (568-626) (see Fig. 5A) and Prosite (567-620) (Fig. S3). Due to this, we decided to add additional aa 
residues to both the N- and C-terminus of the predicted bHLH in order to be sure that we did not destroy any 
structural motif. In this paper we refer to the bHLH domain as area 550-670 aa, additionally divided for the 
N-terminal (550-601) and C-terminal (602-670) part (Fig. 4A).
Results suggested the presence of NESs in two fragments – one comprising the N-terminal part of the bHLH, 
and one comprising the C-terminal part of the bHLH (Fig. 5A). Additionally, we performed a prediction of the 
putative NLS with a cNLS Mapper and got a positive result for aa 569-603 (Fig. 5B) overlapping predicted NESs. 
We decided to experimentally test the activity of all the predicted signals.
First, we prepared the YFP-TCF4/550-601 construct (Fig. 6A) comprising the N-terminal fragment of the 
bHLH. As expected and according to the prediction of the NES in this area, localization of this fragment was 
dominantly localised in cytoplasm of both the COS-7 and N2a cells (Fig. 6Ba,a’). Leptomycin B (LMB) is known 
as an inhibitor of protein transport from the nucleus to the cytoplasm, which depends on a leucine-enriched 
sequence known as classical NES by interaction with exportin-1, which is responsible for protein export from 
the nucleus27–29. As predicted, the NESs were rich in leucine residues (see Fig. 5A). We used LMB to verify our 
hypothesis regarding the presence of an NES in the N-terminus of the bHLH. The presence of LMB resulted in a 
fluorescence signal that was present throughout the whole cell for both the COS-7 (Fig. 6Bb) and N2a (Fig. 6Bb’) 
cells. To exclude the influence of LMB solvent (70% methanol), we added methanol as a control and observed 
cytoplasmic localization of YFP-TCF/550-601 (Fig. 6Bc,c’) similarly to results without LMB addition. These 
results substantiated our hypothesis about the presence of active NES. By analysing different predictor results, we 
hypothesized that a sequence comprising aa 589-598 might be responsible for the NES activity in this fragment. 
To prove this hypothesis, we prepared a mutant where L596 and L598 were substituted by A (YFP-TCF4/550-601/
L596 A/L598A; Fig. 6A). Localization of this mutant changed from being dominantly cytoplasmic for the unmod-
ified fragment to being distributed in both the nucleus and cytoplasm of the cell. Interestingly, the COS-7 and 
N2a cells presented a slightly higher fluorescence signal in the cytoplasm (Fig. 6Bd,d’), suggesting some residual 
activity of NES. The N-terminal extension of NES containing the 550-601 fragment by neighbouring 411-549 aa 
(YFP-TCF4/411-601; Fig. 6A) presented cytoplasmic localization in both the used cell lines (Fig. 6Be,e’), demon-
strating an active NES. The addition of LMB shifted localization to being equally distributed in the nucleus and 
cytoplasm in the COS-7 and the N2a cells (Fig. 6Bf,f ’). Methanol as the control had no influence on localization 
pattern (Fig. 6Bg,g’).
To verify the activity of the predicted NES in the C-terminal part of the bHLH domain, we prepared a 
YFP-TCF4/602-670 construct (Fig. 7A). The expression of this construct resulted in fully cytoplasmic fluores-
cence in the COS-7 cells and cytoplasm prevailing in the N2a cells (Fig. 7Ba). Next, we added LMB and observed 
a shift of localization from the cytoplasm to being equal in the cytoplasm and nucleus (Fig. 7Bb), presenting the 
inhibitory effect of LMB according to the prediction of the NES rich in L residues. Again, addition of methanol 
had no effect (Fig. 7Bc). After detailed analysis of the predictor results (see Fig. 5A), we chose the sequence com-
prising aa 604-618 as a hypothetic NES. To investigate this assumption, we prepared a mutant where L607 and 
L608 were substituted by A (YFP-TCF4/602-670/L607 A/L608 A; Fig. 7A). Localization of this mutant changed 
from being exclusively cytoplasmic, observed for the unmodified fragment, to being distributed equally in both 
compartments of the cell for bothCOS-7 and N2a cells (Fig. 7Bd).
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Our results substantiate the thesis about the presence of one active NES (NES-1) in the N-terminal part 
of the bHLH (589-ELGRMVQLHL-598; bold are leucine residues, bold and underlined are leucine substi-
tuted residue), and the presence of the second active NES (NES-2) in the C-terminal part of this domain 
(604-QTKLLILHQAVAVIL-618).
Figure 4. Subcellular distribution of deletion mutants (188-549aa) of TCF4 (A) Schematic representation of 
TCF4 protein. Region of the studied area of TCF4 is shown by the red rectangle. Expressed deletion mutants of 
TCF4 are depicted as arrows. The length of each domain in the diagram is arbitrary. (B) Subcellular distribution 
of deletion mutants of TCF4. Subcellular localizations of the expressed proteins were analysed by confocal 
microscopy 20-24 h after transfecting COS-7 and N2a cells. Representative images (single confocal plane for 
confocal microscopy) of subcellular distribution of the derivatives of TCF4/188-549 area. Bar, 10 µm. Ratios 
between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar compartments are presented as 
an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a,a’) YFP-TCF4/188-300, (b,b’) YFP-
TCF4/301-367, (c,c’) YFP-TCF4/368-410, (d,d’) YFP-TCF4/411-549, (e,e’) YFP-TCF4/188-367, (f,f ’) YFP-
TCF4/301-410, (g,g’) YFP-TCF4/368-549.
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Surprisingly, the expression of YFP-TCF4/550-670 comprising bHLH (Fig. 8A) resulted in inconsistent 
results, as the COS-7 cells presented highly variable pattern of localization from only cytoplasmic, by distrib-
uted between cytoplasm and nucleus, to mainly nuclear. Repeated experiments have revealed the dependence of 
localization from the time after transient transfection. Microscopy imaging 24 h after transfection of the COS-7 
cells resulted in predominantly cytoplasmic localization (>60% of cells; Fig. 8Ba). However, for some cells we 
also observed equal distribution in both compartments of the cell (<10% cells; Fig. S2), and dominantly nuclear 
localisation for others (approximately 30% cells) (Fig. 8Bb). Repeated imaging 48 h after transfection showed a 
highly dominant nuclear localisation of the bHLH in more than 90% of cells (Fig. 8Bc), while in less than 10% 
of cells we could still observe fluorescence in the cytoplasm (Fig. 8Bd). In the case of the N2a cells, 24 h after 
transfection, dominant nuclear localisation was presented by more than 95% of cells (Fig. 8Be), and we observed 
cytoplasmic fluorescence in only some cells (<5%) (Fig. S2). All the above results suggest the presence of an active 
NLS in the bHLH-containing fragment. The cNLS Mapper predicted the region aa 569-603 as a putative bipartite 
NLS motif rich in basic amino acid residues (see Fig. 5B). Knowing that the N-terminal part of the bHLH (aa 
550-601) presented strictly cytoplasmic localization (see Fig. 6Ba,a’), we deduced that basic amino acid residues 
K602 (predicted as part of NLS) and K606 (not predicted as part of the NLS, however situated in close proximity 
to the predicted NLS) in the C-terminal part of the bHLH are indispensable for this NLS activity. For this reason 
we decided to substitute K606 for A (Fig. 8A). The expression of this point mutant (YFP-TCF4/55-670/K606A) 
in the COS-7 cells mainly resulted (>70%) in equal or slightly more intensive fluorescence in the cytoplasm 
(Fig. 8Bf). However, for some cells (<30%) we could observe localization at the same time in the cytoplasm, but 
could only observe this in some subnuclear punctate aggregates (Fig. S2). In the case of the N2a cells, localization 
was slightly more cytoplasmic (>80%) (Fig. 8Bg). For less than 20% of the N2a cells, the fluorescence signal was 
distributed equally through the cell (Fig. S2). Change of localization after substitution of K606 by A proved the 
importance of this amino acid residue for the detected NLS activity and substantiates the thesis that the motif 
569-RMANNARERLRVRDINEAFKELGRMVQLHLKSDKPQTK-606 (bold are basic residues, bold and under-
lined is lysine substituted residue) is the second active NLS (NLS-2) in TCF4. Out results are consistent with the 
results of Lingbeck et al.40, who documented the presence of the second NLS in the basic region of other proteins 
from the I class bHLH family: E12 and E47.
Figure 5. NES and NLS prediction in the bHLH domain of TCF4. (A) Results of NES prediction using LocNES, 
NES Finder 0,2, NetNES1.1. and ELM servers. (B) Results of NLS prediction using the cNLSMappes server.
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Because of the non-uniform localization of the bHLH, probably caused by the overlapping NLS and NESs, we 
were interested in observing the influence of the NES activity inhibitor (LMB) on the localization of the expressed 
bHLH domain. YFP-TCF4/550-670 (comprising the bHLH and some additional aa) expressed with LMB in the 
COS-7 cells showed dual behaviour, each presented by about 50% of cells - domination in the nucleus (Fig. 8Bh) 
and cytoplasm (Fig. 8Bi). This presented a pattern similar to the expression without LMB, with a delicate shift 
Figure 6. Subcellular distribution of deletion mutants (411-601aa) of TCF4 (A) Schematic representation of 
TCF4 protein. Region of the studied area of TCF4 is shown by the red rectangle. Expressed deletion mutants of 
TCF4 are depicted as arrows. Point mutations are depicted as stars. The length of each domain in the diagram 
is arbitrary. (B) Subcellular distribution of the deletion and point mutants of TCF4. Subcellular localizations 
of the expressed proteins were analysed by confocal microscopy 20-24 h after transfecting COS-7 and N2a 
cells in the absence or presence of additional factors such as LMB or methanol. Representative images (single 
confocal plane for confocal microscopy) of subcellular distribution of the derivatives of TCF4/411-601 area. Bar, 
10 µm. Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar compartments are 
presented as an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a,a’) YFP-TCF4/550-601, 
(b,b’) YFP-TCF4/550-601 after LMB addition, (c,c’) YFP-TCF4/550-601 after methanol addition, (d,d’) YFP-
TCF4/550-601/L596A/L598A, (e,e’) YFP-TCF4/411-601, (f,f ’) YFP-TCF4/411-601 after LMB addition, (g,g’) 
YFP-TCF4/411-601 after methanol addition.
1 0Scientific RepoRtS |         (2019) 9:15629  | https://doi.org/10.1038/s41598-019-52239-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
in the direction of nuclear localization (from about 30% to 50% of the analysed cells). We are not able to clearly 
explain why the NESs in the bHLH of TCF4 are LMB sensitive when separated, while the whole bHLH domain is 
less sensitive. However, we hypothesise that complex multi-element regulation might be the reason for the differ-
entiated response to LMB in the case of the whole bHLH domain (containing two NESs and an NLS) in compar-
ison to the single separated element (NES). LMB addition to the N2a cells expressing YFP-TCF4/550-670 had no 
visible effect (Fig. 8Bj), while without LMB this fragment was already predominantly nuclear in more than 95% 
cells, as discussed above. Controlled addition of methanol as a solvent of LMB had no effect for both the COS-7 
(Fig. 8Bk,l) and N2a (Fig. 8Bm) cells.
Figure 7. Subcellular distribution of the deletion mutant (602-670aa) of TCF4 (A) Schematic representation of 
TCF4 protein. Region of the studied area of TCF4 is shown by the red rectangle. Expressed deletion mutants of 
TCF4 are depicted as arrows. Point mutations are depicted as stars. The length of each domain in the diagram 
is arbitrary. (B) Subcellular distribution of deletion and point mutants of TCF4. Subcellular localizations of the 
expressed proteins were analysed by confocal microscopy 20-24 h after transfecting COS-7 and N2a cells in 
the absence or presence of additional factors such as LMB or methanol. Representative images (single confocal 
plane for confocal microscopy) of subcellular distribution of the derivatives of TCF4/602-670 area. Bar, 10 µm. 
Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar compartments are presented 
as an accumulated bar graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a) YFP-TCF4/602-670, (b) YFP-
TCF4/602-670/L607A/L608A (c) YFP-TCF4/602-670 after methanol addition, (d) YFP-TCF4/602-670 after 
LMB addition.
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Figure 8. Subcellular distribution of the bHLH domain of TCF4 (A) Schematic representation of TCF4 protein. 
Region of the studied bHLH domain of TCF4 is shown by the red rectangle. Expressed deletion mutants of 
TCF4 are depicted as arrows. Point mutation is depicted as a star. The length of each domain in the diagram 
is arbitrary. (B) Subcellular localizations of the expressed proteins were analysed by confocal microscopy in 
COS-7 and N2a cells in the absence or presence of additional factors such as LMB or methanol. Representative 
images (single confocal plane for confocal microscopy) of subcellular distribution of the derivatives of 
TCF4/550-670 area. Bar, 10 µm. (a,b) YFP-TCF4/602-670 -24 h after transfection of COS-7 cells, (c, d) YFP-
TCF4/602-670 - 48 h after transfection of COS-7 cells, (e) YFP-TCF4/602-670 - 24 h after transfection of N2a 
cells, (f) YFP-TCF4/550-670/K606A 24 h after transfection of COS-7 cells, (g) YFP-TCF4/550-670/K606A 
24 h after transfection of N2a cells, (h, i) YFP-TCF4/602-670 24 h after transfection of COS-7 cells in the 
presence of LMB, (j) YFP-TCF4/602-670 24 h after transfection of N2a cells in the presence of LMB, (k, l) YFP-
TCF4/602-670 24 h after transfection of COS-7 cells in the presence of methanol, (m) YFP-TCF4/602-670 24 h 
after transfection of N2a cells in the presence of methanol,
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We intended to further investigate how particular signals in the bHLH domain impact the localization of 
TCF4. First, we prepared a C-terminally truncated mutant without the bHLH domain, instead containing only 
NLS-1 (YFP-TCF4/1-549; Fig. 9A). The expression of this YFP-tagged mutant in the COS-7 cells was strictly 
nuclear, as expected, and presented no fluorescence in the nucleoli (Fig. 9Ba,a’). Some of the COS-7 cells (<10%) 
also presented highly fluorescent puncta in the nucleus (Fig. S2). The YFP-TCF4/1-549 expression in the neu-
ronal N2a cells resulted in a pattern analogical to the COS-7 cells (Fig. 9Bb,b’). Next, we created YFP-TCF4/1-601 
(Fig. 10A) containing both NLS-1 and NES-1. The expressed protein distribution was extremely diversified in 
both the used cell lines (Fig. S4). The COS-7 cells were classified as cells presenting a predominantly nuclear 
(>75% of cells) and predominantly cytoplasmic (<20%) localization (Fig. 10Ba–c), and also presenting an equal 
distribution in both compartments (<5%) (Fig. S4). Additionally, in most cases of nuclear localization, some 
puncta with highly intensive fluorescence in the nucleus were also visible. Similar results were observed for the 
N2a cells, with >70% of the population presenting a nuclear (Fig. 10Bd,e) and <30% cytoplasmic signal of fluo-
rescence (Fig. 10Bf). The addition of methanol did not change distribution (Fig. 10Bg–j), while LMB shifted the 
localization to be exclusively nuclear (Fig. 10Bk,l), proving the active role of NES-1 in directing protein to the final 
destination. We hypothesise that the intensive shift from the cytoplasm to the nucleus in the case of TCF4/1-601 
in comparison to the TCF4/550-670 fragment comes from the presence of an NLS in the N-terminal part of the 
protein. Previously, it was shown that cells expressing TCF4 with a disrupted N-terminal NLS (158-172aa) pre-
sented a slightly dominant nuclear localization. This suggests the synergistic effect of NLSs from the N-terminal 
and C-terminal parts of the TCF4.
Discussion
The subcellular distribution of TCF4 was proposed as one of the mechanisms regulating the function of this 
protein [63]. We showed that the previously documented NLS (NLS-1, Fig. 11A)5, located in the N-terminal part 
of the TCF4 protein (156-178aa), also possesses the putative activity of NoLS. We also showed that additional 
sequences may inhibit nucleolar localization. Our results are substantiated by a previous report stating that in 
cultured cortical- and hippocampus neurons and astrocytes, TCF4 in addition to nucleoplasm and pericarya was 
Figure 9. Subcellular distribution of TCF4 with deletion of the bHLH domain (A) Schematic representation 
of TCF4 protein. Region of the studied area of TCF4 is shown by the red rectangle. Expressed deletion mutant 
of TCF4 is depicted as an arrow. The length of each domain in the diagram is arbitrary. (B) Subcellular 
localizations of the expressed protein was analysed by confocal microscopy 20-24 h after transfecting COS-7 and 
N2a cells. Draq5 was added to the cells for DNA visualization. Representative images (single confocal plane) 
of subcellular distribution of the TCF4/1-549 area. Bar, 10 µm. Ratios between mean fluorescence intensity in 
cytoplasmic, nuclear and nucleolar compartments are presented as an accumulated bar graph (no- nucleolus; 
nu- nucleus, cyt- cytoplasm). (a,a’) YFP-TCF4/188-300 expressed in COS-7 cells, (b,b’) YFP-TCF4/188-300 
expressed in N2a cells.
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also present in the nucleoli. The authors also stated that PTHS–associated dominant-negative mutants R582P and 
R580Trp moderately reduced ribosomal biogenesis and general protein synthesis, pointing out the role of TCF4 
in these processes41.
Figure 10. Hierarchy of NLS and NES signals in TCF4 (A) Schematic representation of TCF4 protein. Region 
of studied area of TCF4 is shown by the red rectangle. Expressed deletion mutant of TCF4 is depicted as an 
arrow. The length of each domain in the diagram is arbitrary. (B) Subcellular localizations of the expressed 
protein were analysed by confocal microscopy 20-24 h after transfecting COS-7 and N2a cells in the absence 
or presence of additional factors such as LMB or methanol. Representative images (single confocal plane for 
confocal microscopy) of subcellular distribution of the TCF4/1-601 area. Bar, 10 µm. Ratios between mean 
fluorescence intensity in cytoplasmic, nuclear and nucleolar compartments are presented as an accumulated bar 
graph (no- nucleolus; nu- nucleus, cyt- cytoplasm). (a-c) YFP-TCF4/1-601 in COS-7 cells, (d-f) YFP-TCF4/1-
601in N2a cells (g,h) YFP-TCF4/1-601 after methanol addition in COS-7 cells, (i,j) YFP-TCF4/1-601 after 
methanol addition in N2a cells (k) YFP-TCF4/1-601 after LMB addition in COS-7 cells (l) YFP-TCF4/1-601 
after LMB addition in N2a cells.
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Additionally, we identified the activity of two NESs (NES-1 and NES-2) and an overlapping NLS (NLS-2) in 
the bHLH domain of TCF4 (Fig. 11A). We performed alignment of TCF4-B+ isoforms of mouse and human 
TCF4, which present a high sequence identity (Fig. 11B), pointing out the conservation of the mosaic pattern of 
Figure 11. (A) Summary of NLSs and NESs in TCF4. Schematic representation of NLSs and NESs residing 
within the TCF4 protein structure. (B) Result of protein sequences alignment of TCF4-B+ isoforms of mouse 
and human TCF4 with ClustalX showing the conservation of TCF4 between these organisms. (C) Model of 
TCF4 generated by Phyre2. 113 residues (17% of protein) encompassing mainly the bHLH domain (aa 567-
620) of TCF4 were modelled with a confidence higher than 90% using the templates: c2mh0A, c5c3lA, c2ql2A 
and c2ypbB. Remaining 601 residues (89%) of TCF4 lacking any template and predicted as disordered were 
modelled by ab initio. NLS-1 and NLS-2 are shown in blue. NES-1 and NES-2 are shown in red. (D) ClustalX 
sequence alignment of TCF4/568-645 region encompassing NLS-2, NES-1 and NES-2 in the bHLH domain 
with corresponding sequences of E12 (aa 547-624), E47 (aa 544-621) and HEB (aa577-654).
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overlaying localization signals with opposing activities between these two organisms. The presence of the NLS 
and NES in close proximity, or overlapping in the bHLH domain, was reported previously for the bHLH-PAS 
transcription factor aryl hydrocarbon receptor (AhR)45 and NPAS446, while two NESs were shown in the bHLH 
of Sima (Drosophila homolog of HIF-1α)47. This suggests a more general function of the bHLH domain in the 
regulation of bHLH proteins shuttling. Laccase and Lefebvre proposed that overlaying of DNA binding motifs 
with localization signals allows for co-ordinate regulation48. We hypothesise that a system that regulates nucle-
ocytoplasmic shuttling of these TF families is very complex and relies on many mutually dependent factors, 
both exportin-1 dependent and independent, like signal masking/unmasking, posttranslational modification and 
interaction with partner proteins such as calmodulin. This enables both precise and flexible signal transduction. 
Such complex multi-element regulation might also be the reason for the differentiated response to the LMB pres-
ence in the COS-7 cells during our experiments: high sensitivity in the case of separated NES-1 and NES-2 in the 
bHLH of TCF4, and low sensitivity in the case of the whole bHLH domain.
Importantly, it has previously been shown that point mutations of basic amino acid residues in the bHLH 
domain of TCF4 were often associated with the Pitt-Hopkins Syndrome. The first identified PTHS-associated 
heterozygous point mutations were R576W and R576Q16,17. Finally, PTHS-association was reported for: G358V, 
D535G, R569W, R572G, R574P, R574H, R576G, R576W, R576Q, R578P, R578H, R580W, R580Q, R582P, R587P, 
A610V and A614V TCF4 human mutants49–53. All the detected basic residue point mutants are localized in the 
NLS-2, while A610V and A614V are seen in the NES-2 sequence, thus suggesting the importance of localization 
signals in PTHS.
Localization studies of PTHS-connected point mutants performed previously, did not give consistent results, 
which was probably due to the different conditions of the performed experiments. Sepp et al.52 expressed wt and 
R576Q, R578H, R580W, R582P and A614 PTHS-associated mutants of TCF4-B− proteins (isoform lacking RSRS) 
in HEK 293 cells, getting an analogical nuclear localization for both the wild type (wt) and all of the mutants. The 
expression of the bHLH tagged with GFP resulted in ubiquitous localization for wt and all the tested mutants. 
Forrest et al.38 performed the expression of G358V, D535G, R578P, R580W and A614V mutants of the TCF4-B+ 
isoform tagged with GFP in the COS-7 cells. Interestingly, while fluorescence for all the expressed proteins was 
visible only in the nucleus, the mutants R578P, R580W, and to a lesser extent A614V formed a small, spherical 
punctate, whose localization differed markedly from the distribution of the wild-type TCF4, G538V and D535G 
mutants. Similar results were obtained in SH- SY5Y neuroblastoma cells. We hypothesize that point mutations 
in the bHLH domain of TCF4, known for PTHS patients, influence pattern of distribution in nucleus and func-
tion of TCF4 probably by changes in DNA binding specificity. However, these single substitutions are not able 
to inhibit NLS-2 activity. In contrast, our experiments have led to the identification of amino acid residue K606 
being indispensable for this NLS activity. Interestingly, this residue has not to date been connected to the PTHS 
disorder. Importantly, human aa residues located in the DNA binding region: R565, R576, E576, R578, R580, 
R587, K603 and K607 refer to murine aa residues R564, R575, E576, R577, R579, R586, K602 and K606 (Fig. 11B), 
which were pointed out by InterPro as being responsible for DNA binding
Localization signals can be structurally exposed, accessible to transport machinery or masked by interacting 
partners. To visualise the arrangement of the detected NLSs and NESs in the TCF4, we generated a 3D model of 
the TCF4 using Phyre2 (Fig. 11C). We also performed in silico analysis of TCF4 structure disorder, and 89% of 
the TCF4 sequence was predicted to be intrinsically disordered. The only area with a tendency to possess a more 
rigid structure was the bHLH domain. Interestingly, for this area we obtained a prediction of the highest surface 
accessibility (Fig. S3). Results of repeated in silico analyses for the selected C-terminal part of the protein (550-
670aa) containing the bHLH domain showed that short intrinsic disorder regions could exist in the external parts 
of this domain (Fig. S5). The preferential location of NLSs and NESs in the intrinsically disordered regions (IDRs) 
of proteins was found to enable flexible and easily accessible interactions with their binding partners54.
IDRs are known to be the targets of intensive posttranslational modifications. Modifications such as phospho-
rylation, especially close to the NLS or NES, have been shown to regulate the intracellular distribution of proteins 
by activating or deactivating localization motifs55. Interestingly, phosphorylation of S448, located very close to the 
bHLH domain, by protein kinase A (PKA) was documented by Sepp and co-workers as being necessary for TCF4 
transcriptional activity in cultured neurons and in the developing brain in vivo33. We performed predictions of 
TCF4 phosphorylation sites and found many putative sites of phosphorylation, especially in the N-terminal part 
of protein with probability higher then 0.5, located in NLS-1 area (aa 156-178): S145, S152, S162, T169, T182. 
We observed much far less predicted sites located in the C-terminus of protein. However, some of the S and T 
residues of TCF4, predicted as putative phosphorylation sites with a probability higher or equal to 0.8, are located 
in the bHLH domain (S600) or in close proximity to this domain (S546, S548, S549, T557, S645, S646, S652). The 
location of putative phosphorylation sites in the C-terminal part of protein is presented in Fig. S5.
Importantly, using three programs, the motif 542-SITRSRSSNND-552 was predicted with a high probability 
as the phosphorylated (S548) binding site for 14-3-3 proteins, which were shown to influence the localization of 
partner proteins with intrinsically disordered regions56. The ubiquitous family of 14-3-3 proteins is involved in 
the regulation of signal transduction57. Binding by 14-3-3 modulates the enzyme activity, subcellular localization, 
structure, stability and molecular interactions of partner proteins58. In this aspect, very interesting is the obser-
vation by Liu et al.59 that TCF4-B− isoform, which encodes full-length protein without motif 545-RSRS-548, 
significantly reduced the promoter containing E-box activity, while the splice variant TCF4-B+ with RSRS did 
not affect this promoter activity in U1240MG cells. Taking all this into account, we hypothesize the importance 
of 14-3-3 interaction for the regulation of TCF4 localization, and in consequence, also this protein activity. On 
the other hand, we cannot exclude that a lack of phosphorylated S548 is the reason for the unbalanced and highly 
differentiated subcellular localization of the expressed TCF4/550-670.
The other mechanism for controlling TCF4 activity by differential subcellular localization could be 
Ca2+-dependent interaction with calmodulin, which was proposed as an important factor in the regulation of 
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various target genes and cellular functions60,61. Though direct experimental data of how Ca2+ could modulate 
TCF4 activity in neurons are still lacking, there are some hypothesis based on studies with class I and II bHLH 
factors about Ca2+-regulated shuttling of TCF4 from the cytoplasm to the nucleus62. Interestingly, it was shown 
that calmodulin binds to the basic sequence of E12, E47 and TCF463, raising the possibility that calmodulin bind-
ing interferes with the activity of localization signals existing in this area.
In this paper, we documented the presence of multiple localization signals with opposing activities, which sug-
gests the complex and precisely balanced regulation of TCF4 subcellular shuttling by masking and unmasking of 
different localization signals in the bHLH domain by interacting partners and posttranslational modifications. We 
performed alignment of the TCF4/568-645 region, encompassing NLS-2, NES-1 and NES-2 in the bHLH domain 
with corresponding sequences of E12 (aa 547-624), E47 (aa 544-621) and HEB (aa577-654). Sequence homology 
in these areas is very high (Fig. 11D), and we therefore propose that not only NLS-2, confirmed by Lingbeck et al. 
[69], but also NES-1 and NES-2 activities might be present in all mammalian E proteins. We therefore believe that 
these signals are important elements that regulate dynamic exchange between the subcellular compartments of 
not only TCF4, but generally bHLH class I transcription factors. The complex interplay of regulatory mechanisms 
of the intracellular localization of TCF4 and other I class bHLH transcription factors requires further studies in 
vivo.
Materials and Methods
plasmid construction. TCF4 cDNA from Mus musculus was a kind gift from Prof. Dr. Moritz J. Rossner 
and dr Magdalena Brzózka (Ludwig-Maximilians University in Munich, Clinic of Psychiatry, Department of 
Molecular Neurobiology, Germany). The full-length cDNA of the canonical B+ isoform of TCF4 (UniProtKB 
- Q60722), with encoding amino acid residues 1-670, was amplified by PCR and cloned into the EcoRI and 
SalI restriction sites of the MCS of the pEYFP-C1 vector (Clontech). Deletion mutants of TCF4 were similarly 
cloned into the pEYFP-C1 vector. The bHLH factor TCF4 should not be confused with the transcription fac-
tor 7-like 2 (TCF7L2; Gene 6934), which is also known as TCF4 (T-cell specific factor 4). The point mutants 
YFP-TCF4/550-601/L596A/L598A, YFP-TCF4/602-670/L607A/L608A, and YFP-TCF4/550-670//K606A were 
obtained by PCR-Mediated Site-Directed Mutagenesis, as described by Ko and Ma64, and cloned with LguI, EcoRI 
and SalI restriction enzymes. All constructs were verified by DNA sequencing.
cell culture and DnA transfection. As described previously65 African green monkey kidney fibroblasts 
COS-7 (ATCC CRL-1651) and Mouse Albino neuroblastoma Neuro 2a (ECACC; Sigma-Aldrich) were cul-
tured in Dulbecco’s modified Eagle medium (DMEM) with 4.5 g/l glucose and L-glutamine (Lonza). The culture 
medium was supplemented with 10% foetal calf serum (FCS). Cells were cultured at 37 °C in a 95% air/5% CO2 
atmosphere. The cells were transfected with 3 μg of DNA/150,000 cells using Xfect Transfection Reagent (Takara 
Clontech) according to the manufacturer’s instructions. LMB (Sigma) was dissolved in 70% methanol at a con-
centration of 10−3 M and added to the medium during transfection at a final concentration of 10−6 M.
electrophoresis and Western blot analysis. To confirm the expression of TCF4 and TCF4 mutants in 
cultured COS-7 cells, additionally to the microscopy experiments, SDS–PAGE and Western blot analysis were 
performed. Samples of the total protein extract were prepared by replacing the cell medium 24 h after transfec-
tion (after washing cells with PBS) with a 2x SDS gel-loading buffer66, transferring extracts to Eppendorf tubes, 
boiling the samples for 5 min and then centrifuging the samples for 5 min (13,000 g). Proteins were separated 
by 10% SDS–PAGE and transferred to a Whatman PROTRAN Nitrocellulose Transfer Membrane (PROTRAN 
BA85, Schleicher and Schuell Pure, Sigma-Aldrich) with mini Trans-Blot apparatus (Bio-Rad). The membrane 
was blocked at room temperature (RT) for 1 h in 3% milk blocking buffer (milk powder; Milchpulver, blotting 
grade, Roth) that was prepared in PBS supplemented with 0.2% Tween 20 (Sigma). Next, the membrane was 
incubated overnight at 4 °C with anti-GFP polyclonal antibodies (Clontech) (diluted 1:300 with milk buffer), 
which cross-reacted with YFP. Secondary goat anti-rabbit antibodies coupled to horseradish peroxidase (Vector 
Laboratories) were added (1:10,000 with milk buffer) and incubated at RT for 2 h. Blots were developed using 
Pierce ECL Plus Western Blotting Substrate (Thermo Scientific) according to the manufacturer’s manual.
Confocal and fluorescence microscopy. As described previously46,67, prior to experiments of confocal 
microscopy imaging, cells were seeded onto 0.17-mm-thick round glass coverslips (Menzel) and submerged in 
a culture medium in 2-cm diameter Petri dishes. Next, 24 h, or in some mentioned cases 48 h after transfection, 
the coverslips with cell cultures were transferred onto a steel holder and mounted on a microscope stage. The 
standard culture medium was replaced with 1 ml of DMEM/F12 without phenol red, buffered with 15 mM HEPES 
(Sigma) and supplemented with 2% FBS (Sigma). Next, 0.1 μl of Draq5 DNA Dye (BioStatus) was added to the 
cells for DNA visualization. During microscopy observation, the cell culture temperature was stabilized at 37 °C 
using a microincubator (Life Imaging Services Box & Cube). Images of the fluorescently labelled proteins were 
acquired using a Leica TCS SP5 II confocal system equipped with argon and helium neon lasers and a 63x oil 
objective lens (NA: 1.4). YFP was excited using 514 nm light and the emitted fluorescence was observed at a range 
of 525-600 nm. The excitation of Draq5 was 633 nm and emission was 650–800 nm. Gamma correction of 0.6 
was set for the Draq-5 channel. At least 50 cells were observed for each cDNA construct in one experiment and 
we calculated the cell percentages by dividing number of cells presenting exact pattern of localization to the total 
number of observed cells multiplying it by 100%. At least three independent experiments were performed for 
each cDNA construct. Images are presented for representative cells with a typical phenotype, which is character-
istic for more than 95% of cases. In the case of cells presenting many phenotypes, representative images of all the 
cell phenotypes are presented. Ratios between mean fluorescence intensity in cytoplasmic, nuclear and nucleolar 
compartments were estimated by measuring mean fluorescence intensity inside each compartment of chosen cell 
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and presented it as an accumulated bar graph. All calculations and transformations were done using ImageJ68. 
Fluorescence microscopy was performed in 2-cm diameter Petri dishes in high glucose DMEM using an Olympus 
IX71 microscope with a YFP filter 24 or 48 hours after transfection.
In silico analysis of the TCF4 sequence. PSIPRED (Protein Structure Prediction Server69; http://www.
psipred.net/psiform.html) was used for predicting the secondary structure of the TCF4. The TCF4 domain 
architecture was predicted using SMART (Simple modular architecture tool70; http://smart.embl-heidelberg.
de), PROSITE (a database of protein families and domains; http://expasy.org/tools/scanprosite/) and CDD (The 
conserved domain database71,72; https://www.ncbi.nlm.nih.gov/cdd/). Protein sequence analysis and prediction 
of the DNA binding site was performed by InterPro (a resource that provides functional analyses of proteins by 
classifying them into families and predicting domains and important sites73; https://www.ebi.ac.uk/interpro/). 
Sequence alignments were obtained using CLUSTAL_X74 (http://www.clustal.org/). Predictions for potential NLS 
sequences were performed using NucPred75, (http://www.sbc.su.se/~maccallr/nucpred/), PSORTII76, (http://
www.psort.org/), and cNLS Mapper77, (http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_y.cgi). Predictions 
of potential NoLS motifs were performed using NoD (Nucleolar localization sequence Detector; http://www.
compbio.dundee.ac.uk/www-nod/)42,78. Predictions of potential NES sequences were performed using the 
NetNes 1.1 server26, (http://www.cbs.dtu.dk/services/NetNES/), ValidNES server79, (http://validness.ym.edu.tw), 
NES Finder 0.2 (http://research.nki.nl/fornerodlab/NES-Finder.htm; and LocNES80 (http://prodata.swmed.edu/
LocNES/LocNES.php). The NetSurfP-2.0 server was used for prediction of the relative surface accessibility of an 
amino acid81, http://www.cbs.dtu.dk/services/NetSurfP/. Predictions of protein disorder were performed using 
PONDR-VLXT82,83, http://www.pondr.com/ and MetaDisorder84, http://iimcb.genesilico.pl/metadisorder, while 
prediction of TCF4 backbone flexibility was performed with DYNAMINE85,86, http://dynamine.ibsquare.be/sub-
mission/. Scanning of the TCF4 sequence for Short linear motifs (SLiMs) was performed with The Eukaryotic 
Linear Motif (ELM) resource87, elm.eu.org. The TCF4-B Mus musculus model was generated using Phyre 288 
http://www.sbg.bio.ic.ac.uk/phyre2. Only 113 residues (17% of protein), encompassing mainly the bHLH domain 
(aa567-620) of TCF4, were modelled with a confidence higher than 90% using the following templates: c2mh0A, 
c5c3lA, c2ql2A and c2ypbB. The remaining 601 residues (89%) of TCF4, lacking any template and predicted to 
be disordered, were modelled by ab initio, which was highly unreliable. Result of TCF4 3D structure prediction 
was visualized with PyMOL (The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.). 
Predictions of phosphorylation sites were performed using the NetPhos 3.1 server89, http://www.cbs.dtu.dk/ser-
vices/NetPhos/ and Disorder Enhanced Phosphorylation Predictor (DEPP)90,91, http://www.pondr.com/cgi-bin/
depp.cgi. 14-3-3-binding sites in the TCF4 were predicted using the 14-3-3-Pred server, combining predictions 
from three different classifiers: ANN, PSSM and SVM92.
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